Lyell Immunopharma, Inc. (LYEL)
34.67
+1.26
(+3.77%)
USD |
NASDAQ |
Dec 12, 16:00
34.67
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ionis Pharmaceuticals, Inc. | 70.27% |
| AnaptysBio, Inc. | 85.45% |
| Ovid Therapeutics, Inc. | 96.91% |
| Cogent Biosciences, Inc. | 94.16% |
| NovaBay Pharmaceuticals, Inc. | 99.98% |